Most Medicare beneficiaries may pay more for drugs under the Inflation Reduction Act

Making prescription drugs more affordable was a key goal of the Inflation Reduction Act (IRA). However, most Medicare beneficiaries may end up paying more out of pocket for medicines as Part D plans adjust to the law’s new provisions, according to a new white paper from the USC Schaeffer Center for Health Policy & Economics.

…